Carregant...
First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
Four large randomised trials of paclitaxel in combination with platinum against a platinum-based control treatment have now been published in full, representing around 88% (3588 out of 4057) of patients randomised into the eight known trials of this question. There is substantial heterogeneity in th...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376171/ https://ncbi.nlm.nih.gov/pubmed/12373593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600567 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|